Inhibrx Biosciences, Inc. Share Price
NASDAQ: INBX | Small CapInhibrx Biosciences, Inc. Stock Performance
Open $87.63 | Prev. Close $85.12 | Circuit Range N/A |
Day Range $80.42 - $88.99 | Year Range $20.68 - $153.68 | Volume 13,491 |
Average Traded $84.19 |
Inhibrx Biosciences, Inc. Share Price Today
As of 10 August 2026, Inhibrx Biosciences, Inc.'s share price is $88.72. The stock opened at $87.63, compared to its previous close of $85.12. During today's trading session, Inhibrx Biosciences, Inc.'s share price traded between $80.42 and $88.99, with an average price of $84.70. Over the past 52 weeks, the stock has recorded a high of $153.68 and a low of $20.68. In terms of performance, Inhibrx Biosciences, Inc.'s share price has risen by 19.58% over the last six months and is up 215.77% on a year-on-year basis.
Inhibrx Biosciences, Inc. Share Price Chart
Inhibrx Biosciences, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.37B | PE Ratio (TTM) -9.81 | Dividend Yield N/A |
EPS (TTM) $-9.04 | Revenue (TTM) $1.30M | Return On Equity (TTM) -1752.22% |
Profit Margin -10773.46% | Debt to Equity 4.23 | Quarterly Earnings Growth YoY 19.62% |
Inhibrx Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
Inhibrx Biosciences, Inc. Annual Profit & Loss
All figures in USD
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Inhibrx Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $81.20 | $88.93 | +8.29% |
Jul 2026 | $94.00 | $82.12 | -13.19% |
Jun 2026 | $102.67 | $94.60 | -8.87% |
May 2026 | $129.22 | $103.81 | -19.00% |
Apr 2026 | $68.46 | $128.16 | +90.80% |
Mar 2026 | $72.00 | $67.17 | -9.46% |
Feb 2026 | $76.28 | $74.19 | -3.04% |
Jan 2026 | $81.85 | $76.52 | -3.16% |
Dec 2025 | $82.28 | $79.02 | -6.40% |
Nov 2025 | $78.54 | $84.42 | +3.89% |
Oct 2025 | $34.08 | $81.26 | +143.59% |
Sep 2025 | $27.98 | $33.36 | +18.74% |
INBX Share Price FAQs
What is Inhibrx Biosciences, Inc. share price today?
What is the 52 week high and 52 week low of Inhibrx Biosciences, Inc. stock?
What is INBX's market capitalisation today?
What is INBX's net income for the last quarter?
What is the 5 year returns of INBX?
What is the high & low stock price of INBX today?
Can I buy INBX shares in India?